Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.

Panés, Julián; Colombel, Jean-Frederic; R D'Haens, Geert; Schreiber, Stefan; Panaccione, Remo; Peyrin-Biroulet, Laurent; V Loftus, Edward; Danese, Silvio; Tanida, Satoshi; Okuyama, Yusuke; Louis, Edouard; Armuzzi, Alessandro; Ferrante, Marc; Vogelsang, Harald; Hibi, Toshifumi; Watanabe, Mamoru; Lefebvre, Jessica; Finney-Hayward, Tricia; Sanchez Gonzalez, Yuri; T Doan, Thao; M Mostafa, Nael; Ikeda, Kimitoshi; Xie, Wangang; Huang, Bidan; Petersson, Joel; Kalabic, Jasmina; M Robinson, Anne; J Sandborn, William

doi:10.1053/j.gastro.2022.02.033

Public

Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.

Shared by NobleBlocks on Jun 1, 2022 • 12:00 AM UTC

Authors:

Julián Panés

Jean-Frederic Colombel

Geert R D'Haens

Abstract

BACKGROUND & AIMS: SERENE UC (Study of a Novel Approach to Induction and Maintenance Dosing With Adalimumab in Patients With Moderate to Severe Ulcerative Colitis) evaluated the efficacy of higher adalimumab induction and maintenance dose regimens in patients with ulcerative colitis. METHODS: This p...

Subject

Adalimumab

Clinical Trial Result

Inflammatory Bowel Disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!